Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer

Background: Hand-foot-skin reaction (HFSR) is an adverse event frequently observed during treatment with capecitabine (cape). In the present analysis, we sought to evaluate the potential association of HFSR and survival in German patients with metastatic colorectal cancer and locally advanced rectal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hofheinz, Ralf-Dieter (VerfasserIn) , Gencer, Deniz (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2 October 2012
In: British journal of cancer
Year: 2012, Jahrgang: 107, Heft: 10, Pages: 1678-1683
ISSN:1532-1827
DOI:10.1038/bjc.2012.434
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1038/bjc.2012.434
Verlag, Volltext: https://www.nature.com/articles/bjc2012434
Volltext
Verfasserangaben:R-D Hofheinz, V Heinemann, LF von Weikersthal, RP Laubender, D Gencer, I Burkholder, A Hochhaus and S Stintzing

MARC

LEADER 00000caa a2200000 c 4500
001 1580059619
003 DE-627
005 20230427065641.0
007 cr uuu---uuuuu
008 180815s2012 xx |||||o 00| ||eng c
024 7 |a 10.1038/bjc.2012.434  |2 doi 
035 |a (DE-627)1580059619 
035 |a (DE-576)510059619 
035 |a (DE-599)BSZ510059619 
035 |a (OCoLC)1341016989 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hofheinz, Ralf-Dieter  |d 1969-  |e VerfasserIn  |0 (DE-588)121917517  |0 (DE-627)08161876X  |0 (DE-576)292991568  |4 aut 
245 1 0 |a Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer  |c R-D Hofheinz, V Heinemann, LF von Weikersthal, RP Laubender, D Gencer, I Burkholder, A Hochhaus and S Stintzing 
264 1 |c 2 October 2012 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.08.2018 
520 |a Background: Hand-foot-skin reaction (HFSR) is an adverse event frequently observed during treatment with capecitabine (cape). In the present analysis, we sought to evaluate the potential association of HFSR and survival in German patients with metastatic colorectal cancer and locally advanced rectal cancer treated with cape in clinical trials. Methods: Patients of the Arbeitsgemeinschaft für Internistische Onkologie (AIO) KRK-0104 and the Mannheim rectal cancer trial were evaluated. HFSR was graded according to NCI-CTC criteria in both trials. Time to first occurrence of HFSR was described per cycle and HFSR developing during cycles 1 and 2 was defined as ‘early HFSR’. Baseline characteristics between the patient groups with or without HFSR were compared using Mann-Whitney-U, Fisher’s exact or χ2-test, as appropriate. Haematological and non-haematological toxicities observed in both groups were compared using Fisher’s exact test. Progression-free (PFS) or disease-free (DFS) as well as overall survival (OS) data from both trials were pooled and the HFSR group was compared with the non-HFSR using Kaplan-Meier analysis. Results: A total of 374 patients were included, of whom 29.3% developed any HFSR. Of these, 51% had early HFSR. Baseline characteristics were comparable between both HFSR groups concerning age, gender, ECOG performance status and UICC stage. On multivariate analysis none of these factors had influence on the occurrence of HFSR. The percentage of all-grade (and grade 3-4) haematological toxicities did not differ between both the groups. By contrast, patients exhibiting HFSR had a significantly higher rate of all-grade (but not grade 3-4) diarrhoea, stomatitis/mucositis and fatigue (P<0.01, respectively). Patients with HFSR had improved PFS/DFS (29.0 vs 11.4 months; P=0.015, HR 0.69) and OS (75.8 vs 41.0 months; P=0.001, HR=0.56). Within the HFSR group, PFS/DFS and OS were comparable between patients with early vs late HFSR. Interpretation: The present analysis provides evidence for the association of HFSR and survival in patients with colorectal cancer. Baseline characteristics, with the exception of UICC stage, older age and ECOG performance status, and the time of occurrence of HFSR had no impact on survival. Patients with HFSR had a higher probability of developing any-grade gastrointestinal toxicity and fatigue while no correlation with haematological toxicity was found. 
700 1 |a Gencer, Deniz  |d 1980-  |e VerfasserIn  |0 (DE-588)140107940  |0 (DE-627)616027850  |0 (DE-576)314627332  |4 aut 
773 0 8 |i Enthalten in  |t British journal of cancer  |d Edinburgh : Nature Publ. Group, 1947  |g 107(2012), 10, Seite 1678-1683  |h Online-Ressource  |w (DE-627)320420094  |w (DE-600)2002452-6  |w (DE-576)103746854  |x 1532-1827  |7 nnas  |a Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer 
773 1 8 |g volume:107  |g year:2012  |g number:10  |g pages:1678-1683  |g extent:6  |a Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |t Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer  |d 2012  |w (DE-627)1446299031  |w (DE-576)376299037 
856 4 0 |u http://dx.doi.org/10.1038/bjc.2012.434  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/bjc2012434  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180815 
993 |a Article 
994 |a 2012 
998 |g 140107940  |a Gencer, Deniz  |m 140107940:Gencer, Deniz  |d 60000  |d 65500  |e 60000PG140107940  |e 65500PG140107940  |k 0/60000/  |k 1/60000/65500/  |p 5 
998 |g 121917517  |a Hofheinz, Ralf-Dieter  |m 121917517:Hofheinz, Ralf-Dieter  |d 60000  |d 65500  |e 60000PH121917517  |e 65500PH121917517  |k 0/60000/  |k 1/60000/65500/  |p 1  |x j 
999 |a KXP-PPN1580059619  |e 3022385099 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer","title":"Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer"}],"language":["eng"],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2 October 2012"}],"recId":"1580059619","type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"6 S."}],"id":{"eki":["1580059619"],"doi":["10.1038/bjc.2012.434"]},"note":["Gesehen am 15.08.2018"],"relHost":[{"part":{"volume":"107","text":"107(2012), 10, Seite 1678-1683","year":"2012","extent":"6","pages":"1678-1683","issue":"10"},"language":["eng"],"title":[{"title":"British journal of cancer","subtitle":"BJC","title_sort":"British journal of cancer"}],"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"note":["Gesehen am 27.10.25"],"disp":"Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancerBritish journal of cancer","id":{"eki":["320420094"],"issn":["1532-1827"],"zdb":["2002452-6"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Edinburgh ; Edinburgh","dateIssuedKey":"1947","dateIssuedDisp":"1947-","publisher":"Nature Publ. Group ; Churchill Livingstone"}],"recId":"320420094","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"BJC"}]}],"name":{"displayForm":["R-D Hofheinz, V Heinemann, LF von Weikersthal, RP Laubender, D Gencer, I Burkholder, A Hochhaus and S Stintzing"]},"person":[{"display":"Hofheinz, Ralf-Dieter","role":"aut","given":"Ralf-Dieter","family":"Hofheinz"},{"display":"Gencer, Deniz","role":"aut","given":"Deniz","family":"Gencer"}]} 
SRT |a HOFHEINZRACAPECITABI2201